XML 37 R20.htm IDEA: XBRL DOCUMENT
v3.20.2

Earn-out Milestone Liability | 6 Months Ended
--- | ---
Jun. 30, 2020
Hercules Warrant [Member] |
Earn-out Milestone Liability | Note 13. Earn-out Milestone Liability Pursuant to the Amended Asset Purchase Agreement entered by and between Company and EGWU, Inc in March 2019, payment of the earnout milestone liability related to the Ovarian Cancer Indication of $12.4 million was modified. The Company has the option to make a $7.0 million payment within 10 business days of achieving the milestone; or make a payment of $12.4 million in cash, common stock of the Company, or a combination of either, within one year of achieving the milestone. As of June 30, 2020, March 31, 2020, and December 31, 2019, the Company fair valued the earn-out milestone liability at $6.0 million, $5.8 million and $5.7 million, respectively and recognized a non-cash charge of $0.2 and $0.3 million for the three-month and six-month periods ended June 30, 2020, respectively. In assessing the earnout milestone liability at June 30, 2020 and March 31, 2020, the Company fair valued each of the two payment options per the Amended Asset Purchase Agreement and weighted them at 80% and 20% probability for the $7.0 million and the $12.4 million payments, respectively. As of June 30, 2019, March 31, 2019, and December 31, 2018, the Company fair valued the earn-out milestone liability at $13.1 million, $5.8 million and $8.9 million, respectively and recognized a non-cash charge of $0.1 million and a non-cash benefit of $3.0 million during the three-month and six-month periods ended June 30, 2019, respectively. In assessing the earnout milestone liability at June 30, 2019 and March 31, 2019, the Company fair valued each of the two payment options per the Amended Asset Purchase Agreement and weighted them at 80% and 20% probability for the $7.0 million and the $12.4 million payments, respectively. The following is a summary of the changes in the earn-out milestone liability for the six-month period ended June 30, 2020:
Balance at January 1, 2020 |  | $ | (5,717,709 | )
Non-cash loss from the change in fair value |  |  | (297,570 | )
Balance at June 30, 2020 |  | $ | (6,015,279 | )
The following is a schedule of the Company’s risk-adjustment assessment of each milestone:
Date |  | Risk-adjustment Assessment of Achieving each Milestone |  |  | Discount Rate |  |  | Estimated Time to Achieve |
June 30, 2020 |  |  | 80 | % |  |  | 9 | % |  | 0.54 to 1.54 years |
March 31, 2020 |  |  | 80 | % |  |  | 9 | % |  | 1.04 to 2.04 years |
December 31, 2019 |  |  | 80 | % |  |  | 9 | % |  | 1.12 to 2.12 years |
June 30, 2019 |  |  | 80 | % |  |  | 9 | % |  | 0.75 to 1.75 years |
March 31, 2019 |  |  | 80 | % |  |  | 9 | % |  | 1.00 to 2.00 years |
December 31, 2018 |  |  | 80 | % |  |  | 9 | % |  | 1.25 years |

X
- References No definition available. + Details
Name: | CLSN_EarnoutMilestoneLiabilityAbstract
Namespace Prefix: | CLSN_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure related to earn-out milestone liabilities. + References No definition available. + Details
Name: | CLSN_EarnoutMilestoneLiabilityDisclosureTextBlock
Namespace Prefix: | CLSN_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration